SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: phbolton who wrote (183)8/13/1998 9:40:00 PM
From: phbolton  Read Replies (1) of 523
 
Neurogen Reports Second Quarter Financial Results
August 11, 1998 06:59 AM
BRANFORD, Conn., Aug. 11 /PRNewswire/ -- Neurogen Corporation NRGN today announced its financial results for the three months ended June 30,1998.
Consistent with the company's expectations for the second quarter, Neurogen reported a net loss of $(2,007,000) or $(0.14) per share, compared to a net loss of $(255,000) or $(0.02) per share for the second quarter of 1997. Neurogen's cash and marketable securities at June 30,1998 were $79,299,000 compared to $84,151,000 at December 31, 1997.

investor.msn.com

also take a look at
investor.msn.com

and

investor.msn.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News